Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 03 Nov, 23:09 UTC

Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera’s approach to drug R&D focuses on “causal intelligence,” which Flagship defines as predicting and understanding cause and effect in biology. The post Flagship Merges 3 Startups…

science

Sources

• T2Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel MedicinesFierce Biotech / Fierce Healthcare / MedCity / GEN03 Nov, 23:09